Know Cancer

or
forgot password

The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety


Phase 3
18 Years
80 Years
Not Enrolling
Female
Madarosis, Hypotrichosis

Thank you

Trial Information

The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety


Inclusion Criteria:



- 18-80 YO females

- madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat
breast cancer

- only breast cancer patients

Exclusion Criteria:

- inability to follow up, apply gel

- active eye/eyelid infection or inflammatory process

- cancer not related to breast cancer, healthy patients

- males

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

eyelash length

Outcome Description:

eyelash ruler used to measure eyelash length

Outcome Time Frame:

6 months

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

9459

NCT ID:

NCT01200251

Start Date:

February 2007

Completion Date:

December 2008

Related Keywords:

  • Madarosis
  • Hypotrichosis
  • Hypotrichosis

Name

Location

Duke University Medical CenterDurham, North Carolina  27710